Nexplanon

News

AstraZeneca and Organon have breached the UK pharma industry's code of practice with promotions for an asthma drug and a contraceptive implant.

News

Agios Pharma has said it will halt clinical development of tebapivat, a PK activator that had reached phase 2 testing in sickle cell disease.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.